Phase 2 Trial of AEZS-108 in Chemotherapy Refractory in Triple Negative Breast Cancer

NCT01698281 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

7

Enrollment

INDUSTRY

Sponsor class

Stopped Poor recruitment

Conditions

Breast Cancer

Interventions

DRUG: AEZS-108
DRUG: SCCC
DRUG: Dexamethasone

Sponsor

AEterna Zentaris